# CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma

Page: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma
Text version: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma.md
Podcast: [Neuro-Oncology: The Podcast](https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653)
Published: 2026-05-04T10:00:00+00:00
Episode link: https://soc-neuro-onc.libsyn.com/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma
Audio file: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-134-.mp3?dest-id=2339594
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma
Duration seconds: 1653

## Resource

Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: David Schiff Podcast Description: Dr. Franziska Ippen interviews Dr. David Schiff on his recent manuscript entitled "CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma"

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.